BE710086A - - Google Patents
Info
- Publication number
- BE710086A BE710086A BE710086DA BE710086A BE 710086 A BE710086 A BE 710086A BE 710086D A BE710086D A BE 710086DA BE 710086 A BE710086 A BE 710086A
- Authority
- BE
- Belgium
- Prior art keywords
- vaccine
- kidneys
- measles
- principle
- virus
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 claims description 12
- 241000282472 Canis lupus familiaris Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 8
- 210000003734 kidney Anatomy 0.000 claims description 8
- 238000003306 harvesting Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- 201000005505 Measles Diseases 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims description 2
- 229940041323 measles vaccine Drugs 0.000 claims description 2
- 230000002349 favourable effect Effects 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- 241000712079 Measles morbillivirus Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010023435 Kidney small Diseases 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18451—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR133690 | 1967-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE710086A true BE710086A (enExample) | 1968-05-30 |
Family
ID=8643705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE710086D BE710086A (enExample) | 1967-12-26 | 1968-01-30 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE710086A (enExample) |
-
1968
- 1968-01-30 BE BE710086D patent/BE710086A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Donahoe et al. | Mullerian inhibiting substance activity in bovine fetal, newborn and prepubertal testes | |
| FR2686097A1 (fr) | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. | |
| Smyth et al. | Further analysis of the factors controlling strobilization, differentiation, and maturation of Echinococcus granulosus in vitro | |
| CN102140435A (zh) | 一种提高水牛体外胚胎生产效率的方法 | |
| Kanungo et al. | Oogenesis in Fundulus heteroclitus. VI. Establishment and verification of conditions for vitellogenin incorporation by oocytes in vitro | |
| CN109136273A (zh) | 制备免疫缺陷的大鼠的方法及其应用 | |
| CH664969A5 (fr) | Lymphokine humain, sa production et son utilisation pour obtenir un anticorps monoclonal specifique de ce lymphokine. | |
| Moustafa et al. | The fate of transplanted cells in mouse blastocysts in vitro | |
| DE2828073C2 (de) | Verfahren zum Kultivieren von Viren | |
| BE710086A (enExample) | ||
| CN112368368B (zh) | 辅助生殖医疗用培养基 | |
| JPH03262488A (ja) | ポドフィロトキシン類化合物の製造法 | |
| CN103881965B (zh) | 一种含海藻糖的牛胚胎体外培养液及培养方法 | |
| CN110872573A (zh) | 一种斑马鱼原代心肌细胞分离与培养的新方法 | |
| US3098011A (en) | Process of producing a vaccine against distemper | |
| CH664574A5 (fr) | Lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations. | |
| US3170839A (en) | Culture process in vitro placental tissue growth medium | |
| DK171576B1 (da) | Fremgangsmåde til udvinding af en cellekultur ved oplukning af nyrer fra slagtesvin ved hjælp af et enzym | |
| Li et al. | A Method for Tissue Culture of Hydra Cells. | |
| CN112741021A (zh) | 一种胚蛋注射蛋壳封口的方法 | |
| CN114381425B (zh) | 经修饰的间充质干细胞及其制备方法和药用组合物 | |
| RU2057176C1 (ru) | Питательная среда для культивирования клеток человека и животных | |
| FR2497103A1 (fr) | Production de facteur de croissance humain | |
| CN103881967B (zh) | 一种含海藻糖的牛卵母细胞体外成熟培养液及培养方法 | |
| JPH03262427A (ja) | ポドフィルム属植物の不定胚の調製方法 |